Shalender Bhasin, MB BS is Professor of Medicine at Harvard Medical School and Director of the Research Program in Men's Health: Aging and Metabolism at Brigham and Women's Hospital, Boston, where he serves as Co-Director of the Center for Transgender Health. Dr. Bhasin has chaired The Endocrine Society's Expert Panel for Developing Clinical Guidelines for Testosterone Therapy and served as Associate Editor of the Journal of Clinical Endocrinology and Metabolism (2004-2009). He served as an Advisor to the WHO Task Force on Male Reproduction. He is Editor-in-Chief of the online AYUR Initiative on Transgender Health for Clinicians (The Endocrine Society of India, 2025). He has received the International Medalist Award of the British Society for Endocrinology (2025), the Lundquist Legends Award (2025), and the Life-Time Achievement Award of the Androgen Society.

Select Guide Rating

• Epidemiology of Male HypogonadismRegulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of HypogonadismDiagnosis and Evaluation of HypogonadismAccurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone LevelsTestosterone Replacement Therapy in Hypogonadal MenMonitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk RatioThe Effects of Testosterone Treatment on Cardiovascular HealthTestosterone Treatment and the Risk of Prostate Adverse EventsFertility Considerations in Hypogonadal MenThe Benefits and Risks of Testosterone Treatment in Older Hypogonadal MenTestosterone, Diabetes Risk, and Diabetes Prevention in MenTesticular Dysfunction Among Cancer SurvivorsTestosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic DiseaseBody Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in MenOptimized Use of the Electronic Health Record and Other Clinical Resources to Enhance the Management of Hypogonadal Men

Shalender Bhasin, MB BS is Professor of Medicine at Harvard Medical School and Director of the Research Program in Men's Health: Aging and Metabolism at Brigham and Women's Hospital, Boston, where he serves as Co-Director of the Center for Transgender Health. Dr. Bhasin has chaired The Endocrine Society's Expert Panel for Developing Clinical Guidelines for Testosterone Therapy and served as Associate Editor of the Journal of Clinical Endocrinology and Metabolism (2004-2009). He served as an Advisor to the WHO Task Force on Male Reproduction. He is Editor-in-Chief of the online AYUR Initiative on Transgender Health for Clinicians (The Endocrine Society of India, 2025). He has received the International Medalist Award of the British Society for Endocrinology (2025), the Lundquist Legends Award (2025), and the Life-Time Achievement Award of the Androgen Society.

Select Guide Rating

• Epidemiology of Male HypogonadismRegulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of HypogonadismDiagnosis and Evaluation of HypogonadismAccurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone LevelsTestosterone Replacement Therapy in Hypogonadal MenMonitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk RatioThe Effects of Testosterone Treatment on Cardiovascular HealthTestosterone Treatment and the Risk of Prostate Adverse EventsFertility Considerations in Hypogonadal MenThe Benefits and Risks of Testosterone Treatment in Older Hypogonadal MenTestosterone, Diabetes Risk, and Diabetes Prevention in MenTesticular Dysfunction Among Cancer SurvivorsTestosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic DiseaseBody Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in MenOptimized Use of the Electronic Health Record and Other Clinical Resources to Enhance the Management of Hypogonadal Men

Shalender Bhasin, MB BS is Professor of Medicine at Harvard Medical School and Director of the Research Program in Men's Health: Aging and Metabolism at Brigham and Women's Hospital, Boston, where he serves as Co-Director of the Center for Transgender Health. Dr. Bhasin has chaired The Endocrine Society's Expert Panel for Developing Clinical Guidelines for Testosterone Therapy and served as Associate Editor of the Journal of Clinical Endocrinology and Metabolism (2004-2009). He served as an Advisor to the WHO Task Force on Male Reproduction. He is Editor-in-Chief of the online AYUR Initiative on Transgender Health for Clinicians (The Endocrine Society of India, 2025). He has received the International Medalist Award of the British Society for Endocrinology (2025), the Lundquist Legends Award (2025), and the Life-Time Achievement Award of the Androgen Society.

Select Guide Rating

• Epidemiology of Male HypogonadismRegulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of HypogonadismDiagnosis and Evaluation of HypogonadismAccurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone LevelsTestosterone Replacement Therapy in Hypogonadal MenMonitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk RatioThe Effects of Testosterone Treatment on Cardiovascular HealthTestosterone Treatment and the Risk of Prostate Adverse EventsFertility Considerations in Hypogonadal MenThe Benefits and Risks of Testosterone Treatment in Older Hypogonadal MenTestosterone, Diabetes Risk, and Diabetes Prevention in MenTesticular Dysfunction Among Cancer SurvivorsTestosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic DiseaseBody Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in MenOptimized Use of the Electronic Health Record and Other Clinical Resources to Enhance the Management of Hypogonadal Men